choline has been researched along with fenofibrate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Campbell, J; Mohiuddin, SM | 1 |
| Choi, HG; Jin, SG; Kim, DW; Kim, JO; Kim, KS; Kim, YH; Mustapha, O; Woo, JS; Yong, CS; Yousaf, AM | 1 |
| Cao, Y; Chen, C; Qi, R; Wang, Y; Xu, L; Zhang, Q | 1 |
| Du, Y; Li, P; Liu, H; Liu, M; Liu, X; Wang, J; Wang, M; Wei, X; Zhang, J | 1 |
| Agarwal, M; Agrawal, N; Daultani, P; Garg, P; Mittal, R; Pawar, P; Rijhwani, P; Singh, VB; Tak, S | 1 |
| Li, HR; Li, SM; Li, Z; Liu, WZ; Liu, ZY; Lu, FZ; Wang, H | 1 |
1 review(s) available for choline and fenofibrate
| Article | Year |
|---|---|
The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes.
Topics: Choline; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents | 2010 |
1 trial(s) available for choline and fenofibrate
| Article | Year |
|---|---|
Choline Fenofibrate Delayed Release Capsules Versus Conventional Fenofibrate Tablets for Dyslipidemia: A Randomized, Non-Inferiority Trial.
Topics: Adult; Biological Availability; Capsules; Choline; Delayed-Action Preparations; Drug Monitoring; Female; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Tablets; Treatment Outcome | 2015 |
5 other study(ies) available for choline and fenofibrate
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs.
Topics: Animals; Area Under Curve; Biological Availability; Carrageenan; Choline; Delayed-Action Preparations; Dogs; Fenofibrate; Solubility; Tablets; Therapeutic Equivalency | 2015 |
Fenofibrate nanoliposome: Preparation and its inhibitory effects on nonalcoholic fatty liver disease in mice.
Topics: Animals; Choline; Fenofibrate; Hypolipidemic Agents; Liposomes; Liver; Methionine; Mice; Nanoparticles; Non-alcoholic Fatty Liver Disease | 2016 |
Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry.
Topics: Administration, Intravenous; Administration, Oral; Animals; Biological Availability; Choline; Chromatography, Liquid; Fenofibrate; Half-Life; Limit of Detection; Liquid-Liquid Extraction; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2017 |
[The swelling behavior of choline fenofibrate hydrogel matrix tablets using dynamic image analysis].
Topics: Choline; Delayed-Action Preparations; Fenofibrate; Hydrogels; Hypromellose Derivatives; Solubility; Tablets | 2016 |